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Abstract. Characterization of the relationship between a kidney tu-
mor’s appearance on cross-sectional imaging and it’s treatment outcomes
is a promising direction for informing treatement decisions and improv-
ing patient outcomes. Unfortunately, the rigorous study of tumor mor-
phology is limited by the laborious and noisy process of making manual
radiographic measurements. Semantic segmentation of the tumor and
surrounding organ offers a precise quantitative description of that mor-
phology, but it too requires significant manual effort. A large publicly
available dataset of high-fidelity semantic segmentations along with clin-
ical context and treatment outcomes could accelerate not only the study
of how morphology relates to outcomes, but also the development of
automatic semantic segmentation systems which could enable such stud-
ies on unprecedented scales. We present the KiTS19 challenge dataset:
a collection of segmented CT imaging and treatment outcomes for 300
patients treated with partial or radical nephrectomy between 2010 and
2018. 210 of these cases have been released publicly and the remain-
ing 90 remain private for the objective evaluation of prediction systems
developed using the public cases.
Keywords: Kidney Tumors · Nephrometry · Semantic Segmentation
1 Background & Summary
There were more than 400,000 kidney cancer diagnoses worldwide in 2018 re-
sulting in more than 175,000 deaths [1], up from 208,000 diagnoses and 102,000
deaths in 2002 [19]. The incidence is higher in developed countries than in devel-
oping countries, and peaks between the ages of 60 and 70 [2]. With the increase
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in abdominal imaging for various unrelated indications, the incidental detec-
tion of asymptomatic renal masses has become increasingly common. This has
increased the proportion of tumors that are small and localized when treated,
which is thought to be a contributing factor to the disease’s increased overall sur-
vival [10]. Some established risk factors for kidney cancer are smoking, obesity,
and hypertension [3]. Historically, removal of both the tumor and affected kid-
ney, termed Radical Nephrectomy (RN), was standard of care for kidney tumors,
but advancements in surgery in conjunction with earlier tumor detection have
precipitated shift in kidney cancer treatment toward more conservative nephron
sparing procedures, termed Partial Nephrectomies (PNs) [21]. These are typi-
cally less invasive and limit renal function impairment, thus they are preferred
when feasible.
In an effort to more reliably quantify tumor details and accurately com-
pare decisions about kidney tumor treatment (notably, the decision between
RN and PN), various nephrometry scoring systems were proposed based on the
tumor’s presentation in cross-sectional imaging. Among these are R.E.N.A.L.
[13], P.A.D.U.A. [6], and the Centrality Index [20]. Once proposed, these scor-
ing systems were found to be associated with surgical approach and a wide
range of clinical outcomes including recurrence after treatment [17,7], benign vs
malignant tumor [18], and high-grade tumor pathology [12]. In spite of their im-
pressive predictive power, existing nephrometry scores characteristically utilize
relatively simple and easy-to-extract image features such as location, degree of
endophycity, and diameter of the tumor. Further, the most popular R.E.N.A.L.
and P.A.D.U.A. scores reduce continuous variables into discrete bins, further lim-
iting their expressive power in favor of more expedient and repeatable manual
evaluation [11]. In contrast, semantic segmentation produces a rich quantitative
representation of the tumor and affected organ, trivializing the precise extrac-
tion of enumerable morphological traits such as contact surface area [15] and
irregularity [22].
Our objectives in releasing this data are (1) to accelerate the research and
development of new nephrometric features to aid in prognosis and treatment
planning for kidney tumors, and (2) to enable the creation of reliable learning-
based kidney and kidney tumor semantic segmentation methods which will allow
the features developed in (1) to be automated and applied at an unprecedented
scale.
2 Methods
We conducted a retrospective review4 of the 544 patients who underwent RN or
PN at our institution between 2010 and mid-2018 to excise a renal tumor. For
326 of these patients, preoperative abdominal CT imaging in the late-arterial
phase was available, and the remaining patients were excluded. To simplify an
unambiguous definition of kidney tumor voxels, all patients with tumor thrombus
4 This work was reviewed and approved by the Institutional Review Board at the
University of Minnesota as Study 1611M00821.
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were also excluded, leaving 300 patients who met our inclusion criteria and
comprise our dataset.
The data collection procedure for each included patient consisted of four
steps: (1) chart review, (2) CT collection, (3) CT annotation, and (4) quality
assurance. This work was done primarily by medical students under the super-
vision of author Christopher Weight, an experienced fellowship-trained urologic
oncologist who specializes in kidney tumors.
2.1 Chart Review
The objective of the chart review phase of the data collection procedure was to
record relevant clinical information about each patient’s demographics, comor-
bidities, intervention, and clinical outcomes. This information was found by a
manual review of each patient’s Electronic Medical Record (EMR) in conjunc-
tion with a database query for certain structured fields. An exhaustive list and
short description of each of the collected attributes from this phase can be found
in Section 3.
2.2 CT Collection
The objective of the CT collection phase of the data collection procedure was to
secure a local copy of the most recent preoperative CT study for each patient
that contained at least one series in late arterial contrast phase that depicts the
entirety of the abdomen (at least). Despite the fact that such imaging is standard
of care for kidney tumors [2], many patients were excluded at this stage because
it was either done at a referring institution and not available to our team, or
MRI was used instead for preoperative planning.
In rare cases where several preoperative studies captured within one week of
each other meet this criteria, preference was given to the study containing the
late arterial series with smallest slice-thickness.
2.3 CT Annotation
Once a patient’s clinical attributes and imaging were collected, they were moved
to the third phase of our data collection procedure: manual delineation of the
kidney and tumor boundaries. To perform these annotations in a distributed
manner, we developed a simple web application based on the HTML5 Canvas
element that allowed users to draw freehand contours on images [9]. All anno-
tations were performed in the transverse plane, and series were regularly sub-
sampled in the longitudinal direction such that the number of annotated slices
depicting any kidney was roughly 50 per patient. Interpolation (described later)
was performed to compute labels for the excluded slices.
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Manual Delineation The students performing these annotations were given
the following instructions:
1. Confirm that the collection of images for this patient depicts the entirety of
all kidneys. Some of the patients found in our review had horseshoe kidneys
or were transplant recipients. These were included so long as the entirety of
all kidneys were shown. Let the ith case have J transverse slices. We will
refer to the voxels from the jth slice of the ith case as I
(i)
j .
2. For each connected component of pixels belonging to a region of interest,
draw a contour which includes the entire renal capsule and any renal tumors
or cysts, but excludes all tissue other than renal parenchyma that appears
more radiodense than the perinephric fat. In slices where the hilum was
present, the students were to introduce a concavity so as to exclude the
bright ureter and renal vessels (see Fig. 1b). Let there be N
(i)
j such contours
in the jth axial section of the ith case. We will refer to the set of voxels
inside one of these contours by A
(i)
j,n.
3. For each connected component of tumor tissue, draw a contour which in-
cludes that tumor component, but excludes all kidney tissue. Effectively,
these contours only specify the interface between the kidney and tumor,
since the rest of the tumor boundary was already specified in step 2 (see
Fig. 1c). Let there be M
(i)
j such contours in the jth image of the ith case.
We will refer to the set of voxels inside one of these contours by C
(i)
j,m.
This annotation procedure enabled the students to provide a complete and
unambiguous representation of the kidneys and kidney-tumor boundary while
limiting the number of tedious, voxel-wise decisions.
Fig. 1. Left: An axial section of a kidney and tumor from the database, I
(i)
j . Middle:
An example of the first contour the students were instructed to draw around the whole
renal capsule and tumor but excluding the intra-hilar structures, ∂A
(i)
j,0. Right: An
example of the second contour the students were instructed to draw which includes the
tumor but excludes all kidney tissue, ∂C
(i)
j,0.
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Thresholding and Hilum Filling It is well-established that kidneys, tumors,
and cysts (HU > 0.0) are significantly more radiodense than fat (HU < -90.0)
[14], thus a simple HU threshold can be used to precisely define the boundary
between the two. Certain CT series, those especially captured with low-dose
techniques [16], exhibit random noise which can degrade the performance of the
threshold-defined boundary. To mitigate this, we convolve a 3x3 mean filter with
each slice before performing a threshold. Experimentally, we determined that a
cutoff of -30.0 HU successfully discriminated perinephric fat and the tissue in
our regions of interest. In certain cases where the CT had a large amount of
noise and no cysts were present, we applied a 7x7 median filter to each slice and
raised the threshold value to 0 HU. We will refer to the set voxels in the jth
slice of the ith case found to be above its respective threshold as S
(i)
j .
Between the manually-drawn contours and the thresholding, we partition the
voxels from our annotated slices into three bins:
1. Loose Background, Bloose, a superset of True Background B, everything
outside of the intersection between the thresholded voxels, S
(i)
j and the union
of all kidney+tumor contour interiors, A
(i)
j
B
(i)
j ⊆ B(i)loose,j = I(i)j \
M
(i)
j⋃
m=1
A
(i)
j,m ∩ S(i)j

2. True Tumor, T , the intersection of the tumor contour interiors, C
(i)
j , with
the kidney contour interiors, A
(i)
j , and threshold, S
(i)
j
T
(i)
j =
M
(i)
j⋃
m=1
A
(i)
j,m ∩ S(i)j
⋂
N
(i)
j⋃
n=1
C
(i)
j,n

3. Strict Kidney, Kstrict, a subset of true kidney, K, voxels which appear in the
intersection of the kidney contour interiors and threshold but not the tumor
contour interiors.
K
(i)
j ⊇ K(i)strict,j =
M
(i)
j⋃
m=1
A
(i)
j,m ∩ S(i)j
⋂
N
(i)
j⋂
n=1
I
(i)
j \ C(i)j,n

These bins are depicted in Fig. 2b. Consider the kidney or cyst voxels excluded
from Kstrict. We refer to these as K
(i)
exc,j = K
(i)
j \K(i)strict,j . By definition:
K
(i)
j = K
(i)
strict,j ∪K(i)exc,j
B
(i)
j = B
(i)
loose,j \K(i)exc,j
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Therefore, if we identify Kexc, we can compute the final ground truth partition,
B,K, and T for each annotated slice.
On inspection and trial we found that reliably delineating the boundary
between the complex intra-hilar structures and kidney parenchyma is not fea-
sible, and to attempt this would only introduce ambiguity and error into our
dataset, something that’s been shown to markedly hinder the performance of
deep learning-based automatic segmentation [8].
To address this, we chose to include these intra-hilar structures in our “kid-
ney” label. We define the boundary for these features to be that line which
spans the concavity formed by the exclusion of this tissue in the manually-
drawn contours (see Fig. 2b). This line, H
(i)
j , is computed by a call to OpenCV’s
convexHull() function followed by convexityDefects(). An heuristic approach
based on location and shape was used to automatically select the correct defect
and these were manually checked and corrected where necessary. Thus, K
(i)
j is
defined by the inclusive interior of the contour given by ∂K
(i)
strict,j ∪H(i)j , where
∂K denotes the set K’s boundary.
Fig. 2. A demonstration of the various stages of the algorithm which produces the
ground truth segmentation masks given the manually-drawn contours, best viewed in
color. Left: The union of all the strict kidney sets, K
(i)
strict,j . Middle: The hilum found
by the heuristic based detection algorithm as well as the true tumor found by the
intersection of the tumor contour with the left figure, K
(i)
strict,j ∪H(i)j . Right: The final
kidney and tumor labels found by including all tissue within the hilum that’s above
the threshold, blue: T
(i)
j , red: K
(i)
j .
Interpolation Until now, we have described only the procedure defining the
ground truth given these manually drawn contours, but for practical reasons
only a fraction of the total number of slices containing a region of interest were
annotated. In order to produce contours for the remaining slices, and interpola-
tion methodology was used. Our algorithm for interpolating contours for the lth
slice from contours drawn in slices l + a and l − b in Algorithm 1. Once these
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contours are inferred, the ground truth is computed just as it is for manually
provided contours.
Algorithm 1 Interpolate Contours
1: function MatchContourPoints(contour1, contour2)
2: result ← []
3: for x in contour1 do
4: mindist ← inf
5: m← Centroid(contour1)
6: for y in contour2 do
7: if ‖x− y‖2 < mindist then
8: mindist← ‖x− y‖2
9: m← y
10: Append((x,m), result)
return result
11: # Populates A
(i)
l , C
(i)
l , W.L.O.G Assume M
(i)
l+a ≥M (i)l+a, N (i)l+a ≥ N (i)l+a
12: # Distance between contours is taken the euclidean distance between centroids
13: Dmax ← 20 # Maximum distance where contours are still morphed together
14: A
(i)
l ← {}
15: for m in {1...M (i)l+a} do
16: P ← nearest of contours from A(i)l−b or {} if nearest is farther than Dmax
17: R← MatchContourPoints(A(i)l−b,m, P )
18: A
(i)
l ← A(i)l ∪
{
a
a+b
∗R[:, 1] + b
a+b
∗R[:, 2]
}
19: for n in {1...N (i)l+a} do
20: P ← nearest of contours from C(i)l−b or {} if nearest is farther than Dmax
21: R← MatchContourPoints(C(i)l−b,n, P )
22: C
(i)
l ← C(i)l ∪
{
a
a+b
∗R[:, 1] + b
a+b
∗R[:, 2]
}
2.4 Code Availability
Make code available for this hilum filling and interpolation. Have own github,
be able to run a demo
2.5 Quality Assurance
Chart Review During chart review, the students were instructed to leave blank
any field that they were not certain about. These fields were then revisited at a
later time by two students. If those students did not agree on the field’s correct
value, author Christopher Weight was consulted to make the final determination.
Imaging Annotations Students performing annotations were instructed to
read the radiology note from the preoperative CT scan in order to properly
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locate and delineate the tumor(s) in concordance with the expert clinician. A
reviewing student examined each and every image-ground truth pair in both
the transverse and coronal planes, checking for consistent boundary treatment,
and once again for concordance with the radiologist’s impression. Cases found
to have minor issues were fixed by this reviewing student directly, and then
accepted, whereas rare cases with major issues were sent back to the first student
for fixing, and subsequent re-review. This second practice helped to not only
reduce the annotation burden on the reviewing student, but also to educate the
annotating students and prevent similar issues in the future. We discuss our
method’s interobserver variability in section 4.
3 Data Records
The imaging and semantic segmentation labels that were used for the 2019 KiTS
Challenge were originally released on GitHub5. The kits19 repository contains a
directory named data/ which has a subdirectory for each case using the naming
convention e.g. case 00123 for case 123. Cases are numbered beginning at 0,
and the first 210 cases (case 00000 - case 00209) comprise the public portion
of the dataset. Within each subfolder is the case’s imaging and segmentation
labels (named imaging.nii.gz and segmentation.nii.gz respectively) as well
as a JSON file with that case’s clinical attributes. A comprehensive specification
of that JSON file can be found below.
– case id (String): A unique identifier for each case. This takes the form
of "case " followed by five digits, where the least significant digits corre-
spond to the case index and unused digits are assigned zero. For instance,
"case 00000", "case 00017", "case 00202"
– age at nephrectomy (Integer): The age of the patient at the time that they
underwent nephrectomy for their renal tumor.
– gender (Categorical): The gender of the patient. This takes one of the fol-
lowing values: {"male", "female"}
– body mass index (Float): The body mass index of the patient at the time
measured nearest to the most recent imaging in the dataset.
– comorbidities (Object - Bitmap): This takes an object with the following
boolean attributes: myocardial infarction, congestive heart failure,
peripheral vascular disease, cerebrovascular disease, dementia,
copd, connective tissue disease, peptic ulcer disease,
uncomplicated diabetes mellitus,
diabetes mellitus with end organ damage, chronic kidney disease,
hemiplegia from stroke, leukemia, malignant lymphoma,
localized solid tumor, metastatic solid tumor, mild liver disease,
moderate to severe liver disease, aids
– smoking history (Categorical): This attribute can take any of the following
values: {"never smoked", "previous smoker", "current smoker"}.
5 https://github.com/neheller/kits19
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– age when quit smoking (Integer): The age at which the patient quit smok-
ing. This takes the value of "not applicable" for cases in which it is not
applicable and null for cases in which it’s not known (22 instances).
– pack years (Integer): An estimate of the number of cigarette pack-years
that this patient has smoked. This takes the value null if it is unknown (67
instances).
– chewing tobacco use (Categorical): This attribute can take any of the fol-
lowing values: {"never or not for more than 3mo", "quit in last 3mo",
"currently chews"}.
– alcohol use (Categorical): This attribute can take any of the following val-
ues: {"never or not in last 3mo", "two or less daily",
"more than two daily", "quit in last 3mo"}.
– intraoperative complications (Object - Bitmap): This takes an object
with the following boolean attributes: blood transfusion,
injury to surrounding organ, cardiac event
– hospitalization (Integer): The number of days this patient spent in the
hospital after their nephrectomy operation. If the patient died before being
discharged from the hospital, this attribute will take the value
"died before discharge".
– ischemia time (Integer): The number of minutes that the kidney was de-
prived of blood during the nephrectomy operation. This takes the value of
"not applicable" for radical nephrectomies and null for partial nephrec-
tomies for which this value is not available (10 instances).
– radiographic size (Float): The size of the tumor reported in the radiology
report.
– pathologic size (Float): The size of the tumor reported in the surgical
pathology report.
– malignant (Boolean): true if the post-operative surgical pathology report
indicates that the tumor was malignant, false otherwise.
– pathology t stage (Categorical): The T-stage reported in the post-operative
surgical pathology report. This takes one of the following {"X", "0", "1a",
"1b", "1c", "2a", "2b", "3", "4"}
– pathology n stage (Categorical): The N-stage reported in the post-operative
surgical pathology report. This takes one of the following {"X", "0", "1"}
– pathology m stage (Categorical): The M-stage reported in the post-operative
surgical pathology report. This takes one of the following {"X", "0", "1"}
– tumor histologic subtype (Categorical): The histologic subtype proved by
surgical pathology. This takes one of the following values {"clear cell rcc",
"clear cell papillary rcc", "papillary",
"chromophobe", "urothelial", "rcc unclassified",
"multilocular cystic rcc", "wilms", "oncocytoma",
"angiomyolipoma", "mest", "spindle cell neoplasm"}.
– tumor necrosis (Boolean): true if the post-operative surgical pathology
report indicates that necrotic tissue is present within the tumor, false if
the report indicates that it is not, and null if the report does not mention
this (23 instances).
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– tumor isup grade (Integer): The WHO ISUP [5] grade of the tumor indi-
cated in the post-operative surgical pathology report. The value of Null is
used for cases where ISUP grade does not apply, such as benign tumors or
Chromophobes.
– clavien surgical complications (Categorical): This takes one of follow-
ing values defined by the Clavien Dindo Grade [4]: {"0", "1", "2", "3a",
"3b", "4", "5"} or null if this could not be determined (1 instance).
– er visit (Boolean): true if the patient visited the ER less than 24 hours
after discharge but was not admitted, false if not, and null if this could
not be determined (2 instances).
– readmission (Boolean): true if the patient was readmitted to a hospital
within 90 days of the surgery, false if not, and null if this could not be
determined (2 instances – e.g. a censor or death date of less than 90 days
after surgery).
– estimated blood loss (Integer): The volume of blood in ml that the sur-
geon estimates was lost during the nephrectomy procedure, or null if this
is not available (1 instance).
– surgery type (Categorical): Takes one of the following values {"open",
"laparoscopic", or "robotic"}.
– surgical procedure (Categorical): Takes one of the following values
{"partial nephrectomy", "radical nephrectomy"}.
– surgical approach (Categorical): Takes one of the following values
{"retroperitoneal", "transperitoneal"}.
– operative time (Integer): The time that the nephrectomy procedure took
in minutes, or null if this could not be retrieved (2 instances).
– cytoreductive (Boolean): true if the nephrectomy was performed for de-
bulking purposes, false otherwise
– positive resection margins (Boolean): true if the post-operative surgical
pathology report indicates that there is malignant tissue still present in the
margins of the excised tissue, false if the report indicates that the margins
are clear.
– last preop egfr (Object): Information about the most recent estimated
Glomular Filtration Rate (eGFR) value that was measured before the nephrec-
tomy. In cases where no preoperative eGFR value was available, this object
takes the value null (57 instances).
• value (Float): The measured value in ml/min. In cases where the value
was 90 or greater, a value of ">=90" was recorded. In cases where the
patient was younger than 16 years old, GFR cannot be reliably estimated
so a value of age<16 was recorded.
• days before nephrectomy (Integer): The number of days before the
nephrectomy that this measurement was taken.
– first postop egfr (Object): Information about the first estimated Glomu-
lar Filtration Rate (eGFR) value that was measured after the nephrectomy.
In cases where no postoperative eGFR value was available, this object takes
the value null (53 instances).
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• value (Float): The measured value in ml/min. In cases where the value
was 90 or greater, a value of ">=90" was recorded. In cases where the
patient was younger than 16 years old, GFR cannot be reliably estimated
so a value of age<16 was recorded.
• days after nephrectomy (Integer): The number of days after the nephrec-
tomy at which this measurement was taken.
– last postop egfr (Object): Information about the most recent estimated
Glomular Filtration Rate (eGFR) value that was measured after the nephrec-
tomy. In cases where one or fewer postoperative eGFR values were available,
this object takes the value null (122 instances).
• value (Float): The measured value in ml/min. In cases where the value
was 90 or greater, a value of ">=90" was recorded. In cases where the
patient was younger than 16 years old, GFR cannot be reliably estimated
so a value of age<16 was recorded.
• days after nephrectomy (Integer): The number of days after the nephrec-
tomy at which this measurement was taken.
– vital status (Categorical): The current vital status of the patient. Takes
one of the following values: {"Censored", "Dead"}
– vital days after surgery (Integer): The number of days after nephrec-
tomy until either the censor date or the date of death.
This data has since been archived by The Cancer Imaging Archive6 where
the imaging and segmentations are stored in DICOM format and the clinical
data has been converted to a single CSV file. Bitmaps within the JSON are
flattened using two underscores, such that for example the value accessed by
[“comorbidities”][“copd”] in the JSON file is stored in the CSV under the column
“comorbidities copd”.
4 Technical Validation
Any large dataset is bound to be imperfect, and this is especially true of semantic
segmentation. Such datasets are still useful, of course, but their utility can be
enhanced by estimating the nature and extent of these imperfections. In order to
characterize the errors in our segmentation labels, we randomly selected 30 cases
from the challenge’s training set and repeated the image annotation process on
this subset. This allowed us to estimate agreement that our annotation process
has with itself, and thus assess the fidelity of the labels. We measured this
agreement using the same metrics as the KiTS19 challenge. This allowed for a
direct comparison to the performance of the automatic systems submitted as
part of the challenge such that an automatic system that is as reliable as or
better than our manual annotation process would be expected to achieve the
same score as that from repeating our annotation process. The results of this
study can be found in table 4.
6 https://wiki.cancerimagingarchive.net/pages/viewpage.action?pageId=
61081171
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Region Manual Mean Dice
Kidney + Tumor 0.983
Tumor Only 0.923
Table 1. The agreement of the manual annotation process with itself measured by the
average Sørenson Dice score over 30 cases randomly selected from the first 210 cases.
5 Usage Notes
In addition to the release of this data, we have also released some Python starter
code which includes scripts to load and visualize the data. This can be found on
GitHub at https://github.com/neheller/kits19.
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